Merck/NewLink Ebola Vaccine Safety Trial Shows No Serious Side Effects, Researchers Report
Reuters: No serious side effects in Merck/NewLink Ebola vaccine test
“The first people vaccinated with an experimental Ebola shot being developed by Merck and NewLink have had no serious side effects so far, but a few experienced mild fever, Swiss researchers said on Tuesday…” (Kelland, 12/2).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.